Clinical Trial

A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors

Name: A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors — clinical trial record (NCT05718895)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CLINCH

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an Open, Multi-center, Phase I Clinical Study of ATG 022 in Patients with Advanced/metastatic Solid Tumors

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2023-01-30; most recent amendment 2026-04-10.

Status change: Not Yet Recruiting → Recruiting 2023-09-08

Trial Details

NCT Number	NCT05718895
Lead Sponsor	Antengene Biologics Limited
Conditions	Advanced/Metastatic Solid Tumors
Enrollment	156 participants
Start Date	2023-03-27
Primary Completion	2027-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-15